Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 15;195(10):1292-1299.
doi: 10.1164/rccm.201608-1630PP.

The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension

Mark R Nicolls  1 , Norbert F Voelkel  2
Affiliations

The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension

Mark R Nicolls et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A speculative model of how a specific endothelial injury could lead to different outcomes depending on the effectiveness of the endogenous antiinflammatory mechanisms. BMPR2 = bone morphogenetic protein receptor 2; IDO = indoleamine 2,3-dioxygenase; Oct4 = octamer-binding transcription factor 4; PD-1/PDL1 = programmed death 1/programmed death ligand 1; Sox2 = sex-determining region y-box 2; Th17 = helper T-cell type 17; Treg = regulatory T cell.
See this image and copyright information in PMC

References

    1. Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF. Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J. 2005;26:1110–1118. - PubMed
    1. Rich S, Kieras K, Hart K, Groves BM, Stobo JD, Brundage BH. Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol. 1986;8:1307–1311. - PubMed
    1. Isern RA, Yaneva M, Weiner E, Parke A, Rothfield N, Dantzker D, Rich S, Arnett FC. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med. 1992;93:307–312. - PubMed
    1. Dib H, Tamby MC, Bussone G, Regent A, Berezne A, Lafine C, Broussard C, Simonneau G, Guillevin L, Witko-Sarsat V, et al. Targets of anti–endothelial cell antibodies in pulmonary hypertension and scleroderma. Eur Respir J. 2012;39:1405–1414. - PubMed
    1. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med. 1995;151:1628–1631. - PubMed

Publication types